Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",blood triglyceride amount,,RS:0000742,WKY,male,0 days,11,,CMO:0000360,serum triglyceride level,,,,231,mg/dl,25.0,82.9156,MMO:0000136,serum triglyceride analysis,,0.0,,PA IV 50mg/kg,19,days,puromycin aminonucleoside (50 mg/kg) ,100410,puromycin aminonucleoside (50 mg/kg) , 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",blood triglyceride amount,,RS:0000742,WKY,male,0 days,10,,CMO:0000360,serum triglyceride level,,,,240,mg/dl,19.0,60.0833,MMO:0000136,serum triglyceride analysis,,0.0,,PA IV 50mg/kg,19,days,controlled enalapril content drinking water (50 mg/l) (for 26 days) then puromycin aminonucleoside (50 mg/kg) ,100411,controlled enalapril content drinking water (50 mg/l) (for 26 days),puromycin aminonucleoside (50 mg/kg) 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",blood triglyceride amount,,RS:0000742,WKY,male,0 days,12,,CMO:0000360,serum triglyceride level,,,,73,mg/dl,5.0,17.3205,MMO:0000136,serum triglyceride analysis,,0.0,,PA IV 50mg/kg,,,puromycin aminonucleoside (50 mg/kg) ,100413,puromycin aminonucleoside (50 mg/kg) , 2479,"Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68.",blood triglyceride amount,,RS:0000742,WKY,male,0 days,12,,CMO:0000360,serum triglyceride level,,,,72,mg/dl,9.0,31.1769,MMO:0000136,serum triglyceride analysis,,0.0,,PA IV 50mg/kg,,,controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days) then puromycin aminonucleoside (50 mg/kg) ,100414,controlled enalapril content drinking water (50 mg/l) (between 63 and 77 days),puromycin aminonucleoside (50 mg/kg)